MEDABOME, INC.
2Patents
2Active
2Granted
46Portfolio score
Filing activity: Nov 18, 2019 → Dec 6, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11267898B2 | Anti-PODXL antibody MAI1738 and its use for cancer treatment | Chemistry; Metallurgy | 0 | Active |
| US11939391B2 | Anti-TfR1 antibody MAb11-22.1 conjugates for cancer treatment | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.